Refractory/Recurrent Peripheral T-cell Lymphoma
1 clinical trials · Condition
◉ Watch Refractory/Recurrent Peripheral T-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma (NCT07164560) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-04-01 |
Track Refractory/Recurrent Peripheral T-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.